STOCK TITAN

BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1:00pm ET, in Las Vegas, NV

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will be presenting at the BofA Securities 2024 Healthcare Conference on May 15, 2024, in Las Vegas, NV. Alexander Hardy, President, and CEO of BioMarin, will be presenting at 10:00am PT / 1:00pm ET. The presentation will be available via live audio webcast and archived on the company's website.

Positive
  • None.
Negative
  • None.

SAN RAFAEL, Calif., May 8, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President, and Chief Executive Officer of BioMarin will present at the BofA Securities 2024 Healthcare Conference on Wednesday, May 15, 2024, at 10:00am PT / 1:00pm ET, in Las Vegas, Nevada.

An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin
Founded in 1997, BioMarin is a global biotechnology Company dedicated to transforming lives through genetic discovery. The Company develops and commercializes targeted therapies that address the root cause of the genetic conditions. BioMarin's unparalleled research and development capabilities have resulted in eight transformational commercial therapies for patients with rare genetic disorders. The Company's distinctive approach to drug discovery has produced a diverse pipeline of commercial, clinical, and pre-clinical candidates that address a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a substantial benefit over existing treatment options. For additional information, please visit www.biomarin.com.

Contacts:


Investors                                                                                             

Media

Traci McCarty                                                                                     

Marni Kottle

BioMarin Pharmaceutical Inc.                                                             

BioMarin Pharmaceutical Inc.

(415) 455-7558                                                                                       

(650) 374-2803

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-present-at-the-bofa-securities-2024-health-care-conference-on-wednesday-may-15-at-1000am-pt--100pm-et-in-las-vegas-nv-302139003.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When will BioMarin present at the BofA Securities 2024 Healthcare Conference?

BioMarin will present at the conference on May 15, 2024.

Who will be presenting at the conference on behalf of BioMarin?

Alexander Hardy, President, and CEO of BioMarin, will be presenting.

Where will the BofA Securities 2024 Healthcare Conference take place?

The conference will be held in Las Vegas, Nevada.

How can I access the presentation by BioMarin?

The presentation will be available via live audio webcast at https://investors.biomarin.com/.

Will the presentation be available after the conference?

An archived version of the presentation will be available on the company's website for a time following the conference.

BioMarin Pharmaceuticals Inc

NASDAQ:BMRN

BMRN Rankings

BMRN Latest News

BMRN Stock Data

13.24B
190.38M
0.87%
100.02%
3.61%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
NOVATO